The Aedes aegypti mosquito
Find information on thousands of medical conditions and prescription drugs.

Chikungunya

Chikungunya is a rare form of viral fever caused by an alphavirus that is spread by mosquito bites from the Aedes aegypti mosquito. The name is derived from the Swahili word meaning "that which bends up" in reference to the stooped posture developed as a result of the arthritic symptoms of the disease. more...

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

This disease was first described in Tanzania, Africa in 1952. An outbreak of Chikungunya was discovered in Port Klang in Malaysia in 1999 affecting 27 people .

A serological test for Chikungunya is available from the University of Malaya in Kuala Lumpur, Malaysia.

It is closely related to O'nyong'nyong virus. (PMID 15891138)

Symptoms

The symptoms of this disease include fever which can reach 39 °C, a rash typically described as petechial or maculopapular usually involving the limbs and trunk, and arthralgia or arthritis affecting multiple joints which can be debilitating in severity. There can also be headache, conjunctival injection and slight photophobia.

Treatment

There is no specific treatment for Chikungunya. The illness is usually self-limiting and will resolve with time. Symptomatic treatment is recommended after excluding other more dangerous diseases.

Read more at Wikipedia.org


[List your site here Free!]


G, N, and P gene-based analysis of Chandipura viruses, India
From Emerging Infectious Diseases, 1/1/05 by Vidya Avinash Arankalle

An encephalitis outbreak in 2003 in children from India was attributed to Chandipura virus. Sequence analyses of G, N, and P genes showed 95.6%-97.6% nucleotide identity with the 1965 isolate (G gene, 7-11 amino acid changes); N and P genes were highly conserved.

**********

Chandipura virus (CHPV, family Rhabdoviridae), was implicated as the cause of a large outbreak of encephalitis in children, involving 329 cases with 183 deaths, from Andhra Pradesh State, India in 2003 (1). On the basis of serologic investigations conducted during the epidemic, CHPV infection led to different clinical manifestations, including subclinical cases, mild fever, and encephalitis; some patients died within 48 hours, while others recovered (1). CHPV was described for the first time in India in 1965, when it was isolated from the serum of a patient with febrile illness (2) during an outbreak of dengue and Chikungunya viruses. The virus was isolated again in 1980 from an encephalopathy patient during an outbreak in children (3). However, the magnitude of the 2003 outbreak was unique. The present study was conducted to understand the relationship of the 2003 isolates with the 1965 strain and to assess association of mutations in (5, N, and P genes with different clinical manifestations.

The Study

During the outbreak investigations, 5 CHPV isolates were obtained in cell culture. Table 1 provides details about these isolates. The 1980 isolate was not available for further analysis. These isolates were subjected to reverse transcription-polymerase chain reaction (RT-PCR), according to the previously described method (1). The primers listed in Table 2 were designed on the basis of published sequences and used to amplify and sequence the G, P, and N genes (4,5). The PCR products were purified by using Wizard PCR preps DNA purification Kit (Promega, Madison,WI) and sequenced by using Big Dye Terminator cycle sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA) and an automatic sequencer (ABI PRISM 310 Genetic Analyzer, Applied Biosystems).

Multiple alignment of nucleotide/amino acid sequences was carried out by using software ClustalX v.1.83. Phylogenetic analyses based on the G, N, and P genes (1593, 1269, 882 nucleotides [nt], respectively) were carried out employing maximum likelihood method in Phylo win software (6). The reliability of different phylogenetic groupings was evaluated by using the bootstrap test, with 1,000 bootstrap replications, available in Phylo_win. CHPV sequences representing 3 encephalitis cases, including 1 fatal case (patient 2, Table) and 2 febrile cases, were compared.

G gene analysis led to the correction of the sequence reported for the 1965 isolate (accession no. J04350). As compared to the 1965 isolate, the only sequence available in the GenBank database, the following differences were noted for all the 2003 epidemic isolates: 1) an addition of 17 nt after position 1457 base; 2) additions at positions 804, 902, and 1558; and 3) deletions at positions 854 and 869. To confirm these mutations, we sequenced the 1965 isolate available with the repository of the institute and noted that the 1965 sequence did not exhibit the deletions or additions mentioned above. The corrected 1965-CHP-G gene sequence was deposited in GenBank (accession no. AY614717) and used for comparisons. When compared with the corrected sequence, the 2003 epidemic isolates did not exhibit the mutations mentioned above. Although Walker and Kongsuwan resequenced part of the G gene of the 1965 isolate (262 nt) and made necessary corrections (7), these were not deposited in GenBank.

The epidemic isolates exhibited 97% [+ or -] 0.3% nucleotide identity (PNI) with each other and 95.6%-96.1% PNI with the 1965 isolate. For CIN0360 and C1N0327 isolates, grown in 2 different cell lines, the PNIs were 100% and 99.9%, respectively. Comparison of partial G gene sequences from clinical samples (N = 3) with the corresponding cell-line isolates documented that, although sequences derived from different clinical samples exhibited unique mutations, except for 1 substitution in CIN0331M isolate (A1167C), no changes were noted (see online Figure 1; available from http://www.cdc.gov/ncidod/EID/ voll lno01/04-0602-G1.htm).

Alignment of deduced amino acid sequences of the G protein (530 amino acids [aa]) from different isolates is depicted in online Figure 2 (available from http://www.cdc.gov/ncidod/EID/vol11no01/04-0602G2.htm). A total of 7 aa substitutions were noted for the epidemic isolates: Leul9Ser, Thr22Ser, Thr219Ala, Gly222Ala, Arg264Lys, His269Pro, and Thr279Ala. In addition, the brain-derived isolate exhibited 4 more substitutions: Ile 16Val, Asn30Ser, lle218Val, and Arg502Lys. This isolate did not replace Pro [right arrow] Met at position 367 seen in other epidemic isolates. Two amino acid substitutions (Lys40Arg and Leu424Val) were seen in the isolates from encephalitis cases (CIN0327M and CIN0327R). One isolate from a febrile patient, CIN0309R, showed an additional substitution, Asp213Val.

N gene analysis showed that the 1965 isolate was 96.5%-97.6% identical at the nucleotide level with the epidemic isolates, whereas the epidemic isolates were 97.7% [+ or -] 0.3% identical with each other. The isolates grown in different cell lines exhibited 99.3%-99.5% PNI. A single amino acid substitution, Lys37Arg, was noted for all epidemic isolates (online Figure 3, available from http://www.cdc.gov/ncidod/EID/voll1no01/04-0602G3.htm). In all isolates except CIN0331M, Asp substituted Glu at 364. Additional substitutions, Val413Ile (brain-derived isolate) and Ala163Thr (CIN0309R, from a febrile case), were present.

For the P gene, among epidemic isolates, the PNI was 97.4% [+ or -] 0.4%, whereas 95.8%-96.8% identity was observed with the 1965 isolate. The isolates grown in different cell lines were 99%-99.7% identical at the nucleotide level. Glu64Asp substitution was present in all the epidemic isolates (online Figure 4; available from http://www.cdc.gov/ncidod/EID/vol11no01/04-0602G4.htm). A unique single amino acid substitution was noted for 3 isolates: Glnl03Arg in CIN0309R (febrile case), IlelSOVal in brain-derived isolates, and Asn257Thr in CIN0327M (encephalitis case). In addition, Gly112Glu substitution was recorded in 4 isolates (CIN0327R, CIN0327M, CIN0309R, and CIN0331M); Ala214Val was present in all except CIN0327R, CIN0360R, and Ile270Val in 3 isolates (C1N0318R, CIN0309R, and CIN0331M).

The Figure presents the phylogenetic status of different epidemic isolates. Overall, different CHPV isolates were not very divergent from each other. For G and P gene-based analyses, the brain-derived isolate was closer to the 1965 isolate. No segregation of fever and encephalitis case-derived isolates was noted. Although the topology for the unrooted N gene-based tree was similar, the 1965 isolate remained on a separate branch.

Conclusions

This study showed that the 2003 epidemic isolates were closely related to the 1965 isolate. PNIs were 95.6%-96.1% for the G gene, which is responsible for virus entry into cells and induction of neutralizing antibodies; 96.5%-97.6% for the N gene, mainly associated with cytotoxic T-lymphocyte responses; and 95.8%-96.8% for the P gene, associated with RNA polymerase. Thus, the epidemic was not associated with extensive mutations in these genes. Adaptation to cell cultures did not result in changes in the partial G gene sequences, except for 1 nt change (A to C at position 1167) for 1 isolate.

The comparison of the deduced amino acid sequences of G protein of 1965 and 2003 isolates documented 7 differences for the epidemic isolates. None of these were in the transmembrane region sequence (482-502 aa) or in the intracytoplasmic region sequence (503-530, the carboxyl end of the protein). No change in the signal sequence was noted for CIN0309R, the only isolate sequenced completely in this region. Additional amino acid substitutions were recorded for the brain-derived isolate. These included Ile16Val, the signal sequence, and Arg502Lys, the transmembrane region sequence. Both N and P proteins were highly conserved, with only 1 aa substitution at positions 37 and 64, respectively. Importance of the amino acid substitutions in these proteins in the pathogenesis of CHPV infection remains to be determined. As modeled by Walker and Kongsuwan (7), major antigenic sites for Vesicular stomatitis virus (New Jersey) neutralization escape mutations correspond to the CHPV G domain exhibiting multiple amino acid changes in epitope VII (Yhr219Ala and Gly222Ala) and epitope VI (Arg264Lys and His269Pro).

Phylogenetic analyses based on G and P genes (Figure) showed that the brain-derived isolate clustered with the 1965 isolate. No segregation of the isolates from encephalitis and febrile cases was noted, regardless of the type of the viral gene examined, a finding that suggests the importance of host factors in influencing the outcome of the infection.

In conclusion, the present study shows that Chandipura viruses isolated from human cases in India in 1965 and 2003 were not very divergent. Although several amino acid differences were recorded in G protein, the importance of these changes in the pathogenesis of CHPV infection needs to be determined. Generation of infectious cDNA clones for 1965 and 2003 isolates and assessment of individual genes in the pathogenesis of CHPV infection may help in understanding the relationship of structure to outcome for CHPV infections.

References

(1.) Rao BL, Basu A, Wairagkar NS, Gore MM, Arankalle VA. Thakare JR et ah A large outbreak of acute encephalitis with high case fatality rate in children in Andhra Pradesh, India in 2003 associated with Chandipura virus. Lancet. 2004;364:869-74.

(2.) Bhatt PV, Rodriguez FM. Chandipura: a new arbovirus isolated in India from patients with febrile illness. Indian J Med Res. 1967;55:1295-305.

(3.) Rodrigues J J, Singh PB, Dave DS, Prasan R, Ayachit V, Shaikh BH, et al. Isolation of Chandipura virus from the blood in acute encephalopathy syndrome, Ind J Med Res. 1983;77:303-7.

(4.) Masters PS. Banerjee AK. Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses. Virology. 1987:157:298-306.

(5.) Masters PS, Bhella RS, Butcher M, Patel B, Ghosh HP, Banerjee AK. Structure and expression of the glycoprotein gene of Chandipura virus. Virology. 1989:171:285-90.

(6.) Galtier N, Gouy M, Gautier C. SeaView and Phylo_win, two graphic tools for sequence alignment and molecular phylogeny. Computer Applications in the Biosciences. 1996;12:543-8.

(7.) Walker PJ, Kongsuwan K. Deduced structural model for animal rhabdovirus glycoproteins. J Gen Virol. 1999:80:1211-20.

Vidya Avinash Arankalle, * Shrotri Sandhya Prabhakar, * Walimbe Atul Madhukar, * Hanumaih, * Pawar Shailesh Dattatraya, * and Mishra Akhilesh Chandra *

* National Institute of Virology, Pune, Maharashtra, India

Address for correspondence: Vidya Avinash Arankalle, Deputy Director and Head. Hepatitis Division, National Institute of Virology, 20-A, Dr Ambedkar Rd, Pune, 411001, Maharashtra India; fax: 91-020-26122669: email: varankalle@yahoo.com

Dr. Arankalle, deputy director of the National Institute of Virology, has been working on hepatitis viruses for 23 years with special contributions to the understanding of hepatitis E. She is also a member of a team that investigates outbreaks of unknown etiology.

COPYRIGHT 2005 U.S. National Center for Infectious Diseases
COPYRIGHT 2005 Gale Group

Return to Chikungunya
Home Contact Resources Exchange Links ebay